These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 32146565)

  • 1. Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients.
    Singh N; Rashid S; Rashid S; Dash NR; Gupta S; Saraya A
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):897-907. PubMed ID: 32146565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary study analyzing the methylated genes in the plasma of patients with pancreatic cancer.
    Park JW; Baek IH; Kim YT
    Scand J Surg; 2012; 101(1):38-44. PubMed ID: 22414467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer.
    Park JK; Ryu JK; Yoon WJ; Lee SH; Lee GY; Jeong KS; Kim YT; Yoon YB
    Pancreas; 2012 Jan; 41(1):95-101. PubMed ID: 21778928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation and role of metastasis suppressor genes in pancreatic ductal adenocarcinoma.
    Mardin WA; Haier J; Mees ST
    BMC Cancer; 2013 May; 13():264. PubMed ID: 23718921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl peptidase like 6 promoter methylation is a potential prognostic biomarker for pancreatic ductal adenocarcinoma.
    Zhao X; Cao D; Ren Z; Liu Z; Lv S; Zhu J; Li L; Lang R; He Q
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32701143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Curia MC; Fantini F; Lattanzio R; Tavano F; Di Mola F; Piantelli M; Battista P; Di Sebastiano P; Cama A
    BMC Cancer; 2019 May; 19(1):452. PubMed ID: 31088413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SERPINB5 and AKAP12 - expression and promoter methylation of metastasis suppressor genes in pancreatic ductal adenocarcinoma.
    Mardin WA; Petrov KO; Enns A; Senninger N; Haier J; Mees ST
    BMC Cancer; 2010 Oct; 10():549. PubMed ID: 20939879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.
    Heitzer E; Artl M; Filipits M; Resel M; Graf R; Weißenbacher B; Lax S; Gnant M; Wrba F; Greil R; Dietze O; Hofbauer F; Böhm G; Höfler G; Samonigg H; Schaberl-Moser R; Balic M; Dandachi N
    Mod Pathol; 2014 Jun; 27(6):906-15. PubMed ID: 24309322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer.
    García-Ortiz MV; Cano-Ramírez P; Toledano-Fonseca M; Cano MT; Inga-Saavedra E; Rodríguez-Alonso RM; Guil-Luna S; Gómez-España MA; Rodríguez-Ariza A; Aranda E
    Clin Epigenetics; 2023 Jul; 15(1):118. PubMed ID: 37481552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant
    Perets R; Greenberg O; Shentzer T; Semenisty V; Epelbaum R; Bick T; Sarji S; Ben-Izhak O; Sabo E; Hershkovitz D
    Oncologist; 2018 May; 23(5):566-572. PubMed ID: 29371474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NPTX2 hypermethylation in pure pancreatic juice predicts pancreatic neoplasms.
    Yao F; Sun M; Dong M; Jing F; Chen B; Xu H; Wang S
    Am J Med Sci; 2013 Sep; 346(3):175-80. PubMed ID: 23360791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling.
    Nones K; Waddell N; Song S; Patch AM; Miller D; Johns A; Wu J; Kassahn KS; Wood D; Bailey P; Fink L; Manning S; Christ AN; Nourse C; Kazakoff S; Taylor D; Leonard C; Chang DK; Jones MD; Thomas M; Watson C; Pinese M; Cowley M; Rooman I; Pajic M; ; Butturini G; Malpaga A; Corbo V; Crippa S; Falconi M; Zamboni G; Castelli P; Lawlor RT; Gill AJ; Scarpa A; Pearson JV; Biankin AV; Grimmond SM
    Int J Cancer; 2014 Sep; 135(5):1110-8. PubMed ID: 24500968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of the SPARC gene promoter and its clinical implication in pancreatic cancer.
    Gao J; Song J; Huang H; Li Z; Du Y; Cao J; Li M; Lv S; Lin H; Gong Y
    J Exp Clin Cancer Res; 2010 Mar; 29(1):28. PubMed ID: 20338068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of tumor suppressor genes methylation in circulating tumor DNA of patients with pancreatic cancer.
    Xin W; Tu S; Yi S; Xiong Y; Fang K; Sun G; Xiao W
    Gene; 2024 Mar; 897():148078. PubMed ID: 38097094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-124 predicts poor prognosis in pancreatic ductal adenocarcinoma patients.
    Sun B; Liu X; Gao Y; Li L; Dong Z
    Br J Biomed Sci; 2016 Oct; 73(4):152-157. PubMed ID: 27922430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal pentraxin II (NPTX2) is frequently down-regulated by promoter hypermethylation in pancreatic cancers.
    Zhang L; Gao J; Li Z; Gong Y
    Dig Dis Sci; 2012 Oct; 57(10):2608-14. PubMed ID: 22806544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma development.
    Dutruel C; Bergmann F; Rooman I; Zucknick M; Weichenhan D; Geiselhart L; Kaffenberger T; Rachakonda PS; Bauer A; Giese N; Hong C; Xie H; Costello JF; Hoheisel J; Kumar R; Rehli M; Schirmacher P; Werner J; Plass C; Popanda O; Schmezer P
    Oncogene; 2014 Jun; 33(26):3401-10. PubMed ID: 23912455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
    Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma.
    Khan IA; Rashid S; Singh N; Rashid S; Singh V; Gunjan D; Das P; Dash NR; Pandey RM; Chauhan SS; Gupta S; Saraya A
    Sci Rep; 2021 Feb; 11(1):2824. PubMed ID: 33531550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis.
    Manoochehri M; Wu Y; Giese NA; Strobel O; Kutschmann S; Haller F; Hoheisel JD; Moskalev EA; Hackert T; Bauer AS
    Mol Oncol; 2020 Jun; 14(6):1252-1267. PubMed ID: 32243066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.